(Public, NASDAQ:BIOL)   Watch this stock  
Find more results for BIOL
+0.031 (5.69%)
Real-time:   2:02PM EST
NASDAQ real-time data - Disclaimer
Currency in USD
Range 0.55 - 0.60
52 week 0.48 - 1.90
Open 0.55
Vol / Avg. 36,598.00/80,540.00
Mkt cap 44.19M
P/E     -
Div/yield     -
EPS -0.33
Shares 76.02M
Beta 2.45
Inst. own 39%
Dec 4, 2017
BIOLASE Inc at Singular Research Best of the Uncovered Conference - 6:00PM EST - Add to calendar
Nov 1, 2017
Q3 2017 BIOLASE Inc Earnings Call - Webcast
Nov 1, 2017
Q3 2017 BIOLASE Inc Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q3 (Sep '17) 2016
Net profit margin -42.68% -29.67%
Operating margin -44.06% -28.88%
EBITD margin - -26.86%
Return on average assets -46.46% -36.51%
Return on average equity -79.62% -74.72%
Employees 225 -
CDP Score - -


IRVINE, CA 92618-1816
United States - Map
+1-949-3611200 (Phone)
+1-949-2736677 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


BIOLASE, Inc. (BIOLASE) is a medical device company that develops, manufactures, markets and sells laser systems in dentistry and medicine. The Company markets, sells, and distributes dental imaging equipment, including cone beam digital x-rays and computer-aided design (CAD)/computer-aided manufacturing (CAM) intra-oral scanners, in-office, chair-side milling machines and three-dimensional (3-D) printers. It offers two categories of laser system products: WaterLase (all-tissue) systems and Diode (soft tissue) systems. Its brand, WaterLase, uses a combination of water and laser energy to perform procedures performed using drills, scalpels, and other traditional dental instruments for cutting soft and hard tissue. It also offers its Diode laser systems to perform soft tissue, pain therapy, and cosmetic procedures, including teeth whitening. Its Waterlase and Diode systems use disposable laser tips of differing sizes and shapes depending on the procedures being performed.

Officers and directors

Jonathan T. Lord M.D. Chairman of the Board
Age: 61
Bio & Compensation  - Reuters
Harold C. Flynn Jr. President, Chief Executive Officer
Age: 50
Bio & Compensation  - Reuters
John R. Beaver Chief Financial Officer, Senior Vice President
Age: 53
Bio & Compensation  - Reuters
Brendan O'Connell Vice President - Finance and Corporate Controller
Age: 38
Bio & Compensation  - Reuters
Holger Arens Vice President, Managing Director of Europe, the Middle East and Africa
Age: 54
Bio & Compensation  - Reuters
James D. Surek Vice President - Sales, Americas
Bio & Compensation  - Reuters
Michael Roux Vice President of Marketing
Bio & Compensation  - Reuters
Matthew Wilson Vice President of Human Resources
Bio & Compensation  - Reuters
Samuel B. Low Vice President - Dental and Clinical Affairs, Chief Dental Officer
Bio & Compensation  - Reuters
George W. Bickerstaff III Director
Age: 61
Bio & Compensation  - Reuters